Crossmark

Homocysteine as a potential indicator of endothelial dysfunction and cardiovascular risk in female patients with borderline personality disorder

Published Online: 2022-01-03

Published Print: 2022-12

Authors

Kern, Katharina

Sinningen, Kathrin

Engemann, Luisa

Maiß, Clara

Hanusch, Beatrice

Mügge, Andreas

Lücke, Thomas

Brüne, Martin http://orcid.org/0000-0002-2507-0561
Funding

Funding for this research was provided by:

dr. georg und marianne kosing stiftung
License Information

Text and Data Mining valid from 2022-01-03

Version of Record valid from 2022-01-03
More Information

Article History

Received: 16 June 2021

Accepted: 24 November 2021

First Online: 3 January 2022

Declarations

:

: This research has been performed in consent with the Declaration of Helsinki and has been approved by the Ethics Committee of the Medical Faculty of the Ruhr-University Bochum, Germany, (Reference number: 18–6456-BR). Written informed consent was obtained from all participants before enrollment.

: Not applicable.

: The authors declare that they have no conflict of interest with regard to the present study.

Document is current